Primary-source record

MaterialTrial registry change

ivonescimab · NCT06637007 registry update

status: RECRUITING → UNKNOWN

Key facts

Filed
Nov 2, 2026, 03:21 PM
Event
Trial registry change
Direction
Neutral
Confidence
Sourced

More on this asset

Nov 5, 2026
03:24 PM
SMMTSummit Therapeutics

ivonescimab · NCT07228832 registry update

Trial registry changeClinicalTrials.gov1 update
Oct 28, 2026
03:22 PM
SMMTSummit Therapeutics

ivonescimab · NCT07158489 registry update

Trial registry changeClinicalTrials.gov
Oct 22, 2026
10:00 AM
SMMTSummit Therapeutics

Summit Therapeutics to Present Ivonescimab Data Across 10 Abstracts at ESMO 2026

Conference presentationCompany press release
Oct 19, 2026
11:00 AM
SMMTSummit Therapeutics

Summit Therapeutics opens Phase II SMT112-216 trial of ivonescimab regimens in 1L advanced ccRCC

Trial registry changeCompany press release1 update
Oct 6, 2026
03:21 PM
SMMTSummit Therapeutics

ivonescimab · NCT07228832 registry update

Trial registry changeClinicalTrials.gov
ivonescimab · NCT06637007 registry update | SimianX AI